From: The prevalence of hyperuricemia in China: a meta-analysis
China | Gender | Age | |||||
---|---|---|---|---|---|---|---|
 |  | ~30 | 31-40 | 41-50 | 51-60 | 61-70 | >70 |
Northern China | Male | 11.6(8.8-15.1) | 16.4(12.7-20.9) | 20.9(16.0-26.7) | 21.0(14.2-29.9) | 17.3(14.4-20.6) | 17.9(13.8-23.0) |
 | Female | 2.6(1.5-4.5) | 3.8(2.4-5.9) | 7.6(5.5-10.2) | 14.3(9.1-21.7) | 13.2(9.5-18.2) | 20.2(14.4-27.6) |
Southern China | Male | 16.8(11.4-24.2) | 24.4(16.3-34.9) | 24.9(19.6-31.2) | 23.5(19.5-27.9) | 22.6(19.7-25.7) | 27.2(22.5-32.4) |
 | Female | 3.1(1.8-5.4) | 3.6(1.7-7.6) | 6.2(3.5-10.7) | 15.1(11.1-20.2) | 19.8(13.6-27.8) | 25.3(17.6-35.0) |
Eastern China | Male | 13.1(9.5-17.7) | 17.4(13.4-22.2) | 20.4(16.7-24.7) | 19.6(16.4-23.2) | 19.9(17.3-22.8) | 24.2(21.0-27.7) |
 | Female | 2.6(1.5-4.6) | 3.5(2.6-6.7) | 6.8(4.2-10.6) | 12.4(9.4-16.2) | 15.3(10.7-21.6) | 22.4(16.2-30.0) |
Western China | Male | 17.5(6.3-40.1) | 29.9(8.3-67.0) | 31.0(18.8-46.4) | 31.2(18.9-46.9) | 25.6(18.7-27.0) | 24.6(10.3-48.1) |
 | Female | 4.7(3.4-6.5) | 4.2(2.6-6.7) | 7.5(5.2-10.6) | 22.9(11.7-39.8) | 24.6(16.1-35.6) | 31.1(24.5-38.6) |
Total | Male | 14.2(10.4-19.2) | 20.1(15.3-26.0) | 22.9(18.9-27.5) | 22.3(18.8-26.2) | 23.3(18.0-24.9) | 24.1(20.6-28.0) |
 | Female | 2.8(1.8-4.5) | 3.5(2.0-6.2) | 6.6(4.5-9.7) | 14.7(11.5-18.6) | 16.8(12.5-22.4) | 23.4(17.7-30.4) |